India Nepal Bangladesh And Sri Lanka Radiotherapy Market Trends

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Size, Share, and Trends Analysis Report Trends

  • Healthcare
  • Published Report
  • Oct 2024
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

“Growing Prevalence of Cancer Disease”

The incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.

Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms.

In 2022, according to an article published in the National Library of Medicine, the number of cases of cancer in India was estimated to be 14,61,427. In India, one in nine people are likely to develop cancer in his/her lifetime.

According to a ResearchGate publication, Bangladesh recorded 156,775 cancer cases in 2020, representing 0.10% of the total population, with 108,990 resulting in fatalities, equivalent to 0.07% of the population (Fig. 1). Cervical cancer ranks as the second most prevalent cancer among women in Bangladesh, with 8,068 reported cases and 5,214 deaths. On a global scale, it is the fourth most common cancer affecting women

Frequently Asked Questions

The market is segmented based on India, Nepal, Bangladesh, and Sri Lanka Radiotherapy Market Segmentation, By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others), Countries (India, Nepal, Bangladesh, and Sri Lanka) – Industry Trends and Forecast to 2031 .
The India Nepal Bangladesh And Sri Lanka Radiotherapy Market size was valued at USD 116.75 USD Million in 2023.
The India Nepal Bangladesh And Sri Lanka Radiotherapy Market is projected to grow at a CAGR of 12.9% during the forecast period of 2024 to 2031.
The market report covers data from the India, Nepal, Bangladesh, and Sri Lanka.